Serenex serenex.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Serenex is an integrated oncology-focused drug discovery and development company. The company aims to improve the lives of cancer patients by developing therapeutic and supportive care products. Serenex's clinical-stage program, SNX-1012, is a supportive care product for chemotherapy and radiation-induced oral mucositis which is scheduled to begin Phase II clinical trials in early 2006. Additionally, Serenex has a pre-clinical small molecule inhibitor of Heat Shock Protein 90 which is scheduled ...Show all

Serenex is an integrated oncology-focused drug discovery and development company. The company aims to improve the lives of cancer patients by developing therapeutic and supportive care products. Serenex's clinical-stage program, SNX-1012, is a suppor...Show all

Company (Acquired)

Phone: 919-281-6001

Fax:

302 East Pettigrew Street

Durham, 27701
North Carolina, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Serenex $80.5M Apr 24, 2008
See all 27 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Serenex Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details

BioAxone Therapeutique

Quebec, Canada
Alive / ActiveBioAxone is a privately owned neuroscience company engaged in the development and commercialization of technologies that target Rho signaling. Established in April 2000 and headquartered in Montreal, Canada, BioAxone has demonstrated expertise in recombinant protein product development and has a focused small molecule program.Login to see details
See all 27 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)